Skip to content

Clinical trials

Phase 3 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20034
20043
20055
20063
20071
20081
20092
20112
20123
20133
20145
20154
20162
20171
20185
20212
20221
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated10
Unknown status7
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
GlaxoSmithKline4
Shandong University3
AO GENERIUM2
CTI BioPharma2
Eisai Inc.2
M.D. Anderson Cancer Center2
McMaster University2
Novartis Pharmaceuticals2
Ostfold Hospital Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia53
Purpura, Thrombocytopenic, Idiopathic24
Purpura, Thrombocytopenic8
Hematologic Diseases7
Hemorrhage6
Purpura6
Anemia2
Blood Platelet Disorders2
Bone Marrow Diseases2
Ecchymosis2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.